suzanne, republican caller. hello there. >> good morning. hi, liz. i'm a fan of your work and i just wanted to know whether or not you mentioned something about that we're not at war anymore so, i mean, most people do consider us, this country, still engaged in a war on terror and also is it relevant at all that you're producing partner for the past ten years has 11 laurie kennedy, who is a far left wing activist? i was wondering if you could, you know, at least be honest about your political background of your company and kind of left wing agenda that you have. thank you. >> what do you say, liz garbus? >> i didn't mean to say we weren't at war. certainly there's a war going on in iraq, there's a lot of military activity going on in many regions so i didn't mean to indicate we were not at war. what i meant when i said the so-called war on terror is that's what it was called during the bush administration and currently today we aren't calling it the war on terror. that was more of a semantic argument. i do think we are in a time of national crisis an

of systematic reviews and comparative effectiveness that is now being advocated for drugs, and by suzanne procedures boots amici transparence it would be transparency of the criteria you have used to it that day. steady t-shirt meta-analysis in lst belove that they can't judge what is going to be analyzed. >> you are absolutely right. >> i am karen. >> absolutely, i think there to issues. one is, the work that is done especially in these data syntheses meta-analysis petr take into many different studies we at to see what goes into it and what doesn't go into it, but i think the bottom line though it is because it is such an issue of interpretation that the interpretation has to be done by scientists you don't have the financial interest. there was a huge separate couple of years ago when the national institute of health had the panel that opined on what level cholesterol should trigger taking different sorts of statin drugs, and it turns out seven out of those eight scientists who were on the panel had a financial connection to the drug makers to make the statins. and of course many peopl